Table 3.
The characteristics of the cases of P. ovale malaria
| No. | Year | Country | Type of RDTs | Result of RDTs (T1/T2, P.f, Pan)* |
Parasitemia (%) |
PCR |
|---|---|---|---|---|---|---|
| 1 | 2004 | Ghana | BN | −/− | 0.030 | Po |
| 2 | 2005 | Senegal | BN | −/− | 0.060 | Po |
| 3 | 2006 | Uganda | ND | ND | 0.040 | Po |
| 4 | 2007 | Uganda | BN | −/− | 0.040 | Po |
| 5 | 2008 | Uganda | SDMA | −/− | 0.001 | Po |
| 6 | 2009 | Ghana | SDMA | −/+ | 0.080 | Po |
| 7 | 2010 | Uganda | SDMA | −/+ | 0.004 | Po |
| 8 | 2010 | Ghana | SDMA | −/− | 0.012 | Po |
| 9 | 2012 | Uganda | BN | −/− | 0.042 | Po |
| 10 | 2013 | Uganda | BN | −/− | 0.003 | Po |
BN: Binax NOW® malaria; SDMA: SD malaria antigen®; M: male; F: female; ND: not described, Po: Plasmodium ovale.
*T1: the positive band of Histidine rich protein 2 and T2: the positive band of aldolase for BN, P.f: the positive band of Plasmodiun falciparum lactate dehydrogenase (LDH) and Pan: the positive band of Plasmodium LDH, for SDMA.